RMD vs MSFT: Which Stock is Better?

Side-by-side comparison of Resmed Inc and Microsoft Corp in 2026

Comparison Updated:

RMD

Resmed Inc

$256.26

MSFT

Microsoft Corp

$397.23

Key Metrics Comparison

MetricRMDMSFTWinner
Market Cap$37.41BN/ARMD
P/E Ratio25.3236.30RMD
EPS (TTM)$10.12$13.70MSFT
Revenue Growth0.1%14.9%MSFT
Gross Margin61.5%68.8%MSFT

Analyze RMD

Full quant analysis

Analyze MSFT

Full quant analysis

Analyze Each Stock

Frequently Asked Questions

Is RMD or MSFT a better investment?

Comparing RMD and MSFT: Resmed Inc has a market cap of $37.41B while Microsoft Corp has N/A. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.

What is the difference between RMD and MSFT?

RMD (Resmed Inc) and MSFT (Microsoft Corp) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.

Which stock has better value: RMD or MSFT?

Based on P/E ratios, RMD trades at a lower multiple (25.3x vs 36.3x).

Which is growing faster: RMD or MSFT?

MSFT has higher revenue growth at 14.9% vs 0.1% for RMD.

Which company is more profitable: RMD or MSFT?

Microsoft Corp (MSFT) has higher gross margins at 68.8% compared to 61.5% for RMD.

Which is the larger company: RMD or MSFT?

Resmed Inc (RMD) is larger with a market cap of $37.41B compared to N/A for MSFT.

Should I buy RMD or MSFT in 2026?

Both RMD and MSFT have investment merit. RMD trades at $256.26 while MSFT trades at $397.23. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.

What are the key differences between RMD and MSFT stock?

Key differences: Market Cap ($37.41B vs N/A), P/E Ratio (25.3x vs 36.3x), Revenue Growth (0.1% vs 14.9%), Gross Margin (61.5% vs 68.8%).

Popular Stock Comparisons